MAPS, the state’s prescription drug monitoring program, is a software tool that provides prescribers and dispensers with real-time prescription data and analytics of controlled substances and schedule 2-5 drugs that have been dispensed. MAPS helps clinicians to make informed decisions and provides resources to better assess a patient’s risk for substance use disorder. To promote patient safety, Public Act 248 of 2017 requires prescribers to register with MAPS and before prescribing a Schedule 2-5 controlled substance, exceeding a three-day supply, must review a MAPS report.
If your question(s) pertain to the new opioid legislation, we encourage you to review the recently-released FAQs. Please email any additional questions that you have regarding the FAQs to BPL-MAPS@michigan.gov and the LARA and DHHS policy teams will review and determine whether the FAQs need to be updated. Please call our customer support team if you have questions about how to register for or use MAPS.
State and federal governments are acting to reduce improper prescribing of prescription drugs. Information on prescribing guidelines are updated monitoring systems is provided in this section.
The State of Michigan and the federal government are acting to reduce misuse of prescription drugs. Information on the updated prescription drug monitoring program and the naloxone standing order is found here.
NATIONAL SUBSTANCE ABUSE HOTLINE
If you or someone you know needs help with substance abuse, please call the SAMHSA Abuse Hotline.
The state of Michigan has multiple initiatives to combat
the Opioid crisis. Our resources are available to you.